ArticleScientific reports2025

Cost effectiveness and pricing strategy of first line benmelstobart combination treatment for extensive stage small cell lung cancer in China.

Shan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.